MAPT antibody (Ser404)
Quick Overview for MAPT antibody (Ser404) (ABIN574182)
Target
See all MAPT AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Ser404
-
Specificity
- Endogenous levels of total Tau protein
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthesized non-phosphopeptide derived from human Tau around the phosphorylation site of serine 404 (D-T-SP-P-R).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (15 μg/mL), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Alternative Name
- MAPT / tau
-
Background
-
Name/Gene ID: MAPT
Synonyms: MAPT, FTDP-17, MSTD, Neurofibrillary tangle protein, PHF-tau, MTBT2, PPND, DDPAC, MAPTL, MTBT1, Paired helical filament-tau, TAU -
Gene ID
- 4137
-
Pathways
- MAPK Signaling, Microtubule Dynamics, M Phase, Regulation of Cell Size
Target
-